STOCK TITAN

The BC Bud Co Closes Upsized 3rd and Final Tranche of Financing

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

The BC Bud (BCBCF) has successfully closed the third and final tranche of its oversubscribed non-brokered private placement, raising $506,436 through the sale of 6,752,483 units at $0.075 per unit. Each unit includes one common share and one warrant exercisable at $0.15 for 24 months.

The company previously raised $631,300 in the first tranche and $511,275 in the second tranche, bringing total proceeds to $1,649,011 through 21,986,813 units. The third tranche involved finder's fees of $21,912 and 292,160 finder warrants.

Additionally, BCBCF plans to extend the expiry date of 6,800,000 prior warrants from February 2, 2025, to February 2, 2026, subject to CSE approval. The proceeds will be used for business development and working capital.

BC Bud (BCBCF) ha concluso con successo la terza e ultima tranche del suo collocamento privato non mediato, sovra-sottoscritto, raccogliendo $506,436 attraverso la vendita di 6,752,483 unità a $0.075 per unità. Ogni unità include una azione comune e un warrant esercitabile a $0.15 per 24 mesi.

L'azienda aveva precedentemente raccolto $631,300 nella prima tranche e $511,275 nella seconda tranche, portando il totale a $1,649,011 attraverso 21,986,813 unità. La terza tranche ha comportato commissioni per il finder di $21,912 e 292,160 warrant per il finder.

Inoltre, BCBCF prevede di estendere la data di scadenza di 6,800,000 warrant precedenti dal 2 febbraio 2025 al 2 febbraio 2026, soggetto all'approvazione della CSE. I proventi saranno utilizzati per lo sviluppo aziendale e il capitale circolante.

BC Bud (BCBCF) ha cerrado con éxito la tercera y última tranche de su colocación privada no mediada, sobre suscripta, recaudando $506,436 a través de la venta de 6,752,483 unidades a $0.075 por unidad. Cada unidad incluye una acción común y una opción de compra que se puede ejercer a $0.15 durante 24 meses.

La compañía había recaudado anteriormente $631,300 en la primera tranche y $511,275 en la segunda tranche, lo que eleva el total a $1,649,011 a través de 21,986,813 unidades. La tercera tranche involucró comisiones para el buscador de $21,912 y 292,160 opciones de compra para el buscador.

Además, BCBCF planea extender la fecha de vencimiento de 6,800,000 opciones de compra anteriores del 2 de febrero de 2025 al 2 de febrero de 2026, sujeto a la aprobación de la CSE. Los fondos se utilizarán para el desarrollo empresarial y el capital de trabajo.

BC Bud (BCBCF)는 성공적으로 초과 청약된 비중개 사모 배정의 세 번째이자 마지막 트렌치를 마감했으며, $506,436를 모집하여 6,752,483개 단위가 $0.075 각각의 가격으로 판매되었습니다. 각 단위에는 한 주식과 24개월 동안 $0.15에 행사할 수 있는 워런트가 포함됩니다.

회사는 이전에 첫 번째 트렌치에서 $631,300을 모금했으며, 두 번째 트렌치에서는 $511,275을 모금하여 총 수익이 $1,649,011이 되었습니다. 세 번째 트렌치에서는 $21,912의 파인더 수수료와 292,160개의 파인더 워런트가 포함되었습니다.

또한, BCBCF는 6,800,000개의 이전 워런트의 만료일을 2025년 2월 2일에서 2026년 2월 2일로 연장할 계획이며, 이는 CSE의 승인을 받습니다. 수익은 사업 개발과 운전 자본에 사용될 예정입니다.

BC Bud (BCBCF) a réussi à clore la troisième et dernière tranche de son placement privé non médié par des intermédiaires, sursouscrit, levant $506,436 grâce à la vente de 6,752,483 unités à $0.075 par unité. Chaque unité comprend une action ordinaire et un warrant exerçable à $0.15 pendant 24 mois.

L'entreprise avait précédemment levé $631,300 lors de la première tranche et $511,275 lors de la deuxième tranche, portant le total des recettes à $1,649,011 par le biais de 21,986,813 unités. La troisième tranche a impliqué des frais de recherche de $21,912 et 292,160 warrants de recherche.

De plus, BCBCF prévoit de prolonger la date d'expiration de 6,800,000 warrants antérieurs du 2 février 2025 au 2 février 2026, sous réserve de l'approbation de la CSE. Les produits seront utilisés pour le développement commercial et le fonds de roulement.

BC Bud (BCBCF) hat erfolgreich die dritte und letzte Tranche seines überzeichneten nicht vermittelten Privatplatzierungsangebots abgeschlossen und $506,436 durch den Verkauf von 6,752,483 Einheiten zu je $0.075 eingeworben. Jede Einheit beinhaltet eine Stammaktie und einen Warrants, der für 24 Monate zu $0.15 ausgeübt werden kann.

Das Unternehmen hatte zuvor $631,300 in der ersten Tranche und $511,275 in der zweiten Tranche eingeworben, was die Gesamteinnahmen auf $1,649,011 durch 21,986,813 Einheiten bringt. Die dritte Tranche beinhaltete Findergebühren von $21,912 und 292,160 Finder-Warrants.

Darüber hinaus plant BCBCF, das Ablaufdatum von 6,800,000 vorherigen Warrants vom 2. Februar 2025 auf den 2. Februar 2026 zu verlängern, vorbehaltlich der Genehmigung durch die CSE. Die Einnahmen werden für die Geschäftsentwicklung und als Betriebskapital verwendet.

Positive
  • Successfully raised total proceeds of $1,649,011 through oversubscribed placement
  • All three tranches of financing completed, demonstrating strong investor interest
Negative
  • Dilution of existing shareholders through issuance of 21,986,813 new units
  • Additional potential dilution from exercise of warrants and finder warrants

Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - The BC Bud Corporation (CSE: BCBC) (OTC Pink: BCBCF) (FSE: W04) ("The BC Bud Co" or the "Company"), is pleased to announce that it has closed the third and final tranche of its oversubscribed previously announced non-brokered private placement (the "Placement") (see news releases dated January 9, 2025, January 17, 2025 and January 24, 2025).

Under the third tranche of the Placement, the Company raised gross proceeds of $506,436 through the sale of 6,752,483 units at a price of $0.075 per unit (each a "Unit"). Each Unit is comprised of one common share (a "Common Share") and one share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to acquire an additional Common Share at a price of $0.15 per Common Share for a period of 24 months. The Company previously closed the first tranche of the Placement on January 17, 2025 for aggregate gross proceeds of $631,300 and the second tranche of the Placement on January 24, 2025 for aggregate gross proceeds of $511,275. To date, the Company has raised aggregate gross proceeds of $1,649,011 through the sale of 21,986,813 Units.

In connection with the third tranche of the Placement, the Company: (i) paid to certain finders an aggregate cash commission of $21,912; and (ii) issued to certain finders an aggregate of 292,160 finders warrants (the "Finder Warrants"). Each Finder Warrant will be exercisable into one unit of the Company ("Finder Unit") at a price of $0.075 per Finder Unit for a period of 24 months from January 29, 2025, with each Finder Unit comprised of one Common Share and one Warrant.

All securities issued in the third tranche are subject to a statutory hold period expiring on May 30, 2025, in accordance with applicable securities legislation.

Net proceeds of the Placement will be utilized for business development and general working capital purposes.

Warrant Extension

The Company is also pleased to announce that it intends to extend the expiry date of an aggregate of 6,800,000 common share purchase warrants (the "Prior Warrants") issued under a previous non-brokered private placement completed on February 2, 2023. Each Prior Warrant is currently exercisable into one Common Share of the Company at an exercise price of $0.15 per Common Share until February 2, 2025. Subject to the approval of the Canadian Securities Exchange (the "CSE"), the expiry date of the Prior Warrants will be extended to February 2, 2026. All other terms of the Prior Warrants will remain the same.

About The BC Bud Co.
The B.C. Bud Co. is a house of brands created by industry professionals who are passionate about the user experience.

On behalf of the board of directors of The BC Bud Co.

Brayden Sutton
Chief Executive Officer and Director

Investor Relations
Phone: 1-(778)-656-0377
Email: info@thebcbc.com
Web: www.thebcbc.com

Disclaimer
Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the anticipated use of the net proceeds of the Placement, the Company's intention to complete the warrant extension and that the warrant extension will be effected. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

In making the forward-looking statements in this news release, the Company has applied certain material assumptions, including without limitation, that the Company will use the net proceeds of the Placement as currently anticipated, that the Company will not run into regulatory or other barriers in carrying out its business plans, and that the Company will obtain all required corporate and regulatory approvals for the warrant extension. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, that the Company will not use the net proceeds of the Placement as currently anticipated and that the Company may not obtain CSE and other required approvals to effect the warrant extension

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238894

FAQ

How much did The BC Bud Co (BCBCF) raise in its third tranche of financing?

The BC Bud Co raised $506,436 in the third tranche through the sale of 6,752,483 units at $0.075 per unit.

What are the total proceeds raised by BCBCF across all three tranches?

BCBCF raised total aggregate proceeds of $1,649,011 through the sale of 21,986,813 units across all three tranches.

What is the exercise price and expiry period for BCBCF's new warrants?

The warrants have an exercise price of $0.15 per Common Share and are valid for a period of 24 months.

What is BCBCF planning to do with the 6,800,000 prior warrants from February 2023?

BCBCF plans to extend the expiry date of these warrants from February 2, 2025, to February 2, 2026, subject to CSE approval.

How will BCBCF use the proceeds from this financing?

The net proceeds will be utilized for business development and general working capital purposes.

BC BUD CORP

OTC:BCBCF

BCBCF Rankings

BCBCF Latest News

BCBCF Stock Data

10.23M
69.35M
Investment Banking and Securities Dealing
Finance and Insurance
United States of America